The VF recognizes the importance of encouraging and supporting research to gain a better understanding and knowledge of vasculitis.

The VF Research Grant Program was established in 2001 and provides one and two year grants to support pilot studies investigating the causes of vasculitis, developing more effective treatments and improving diagnostic tools.

Following are some of the studies funded by the VF.

• Short-term cyclophosphamide therapy in a cohort of over 200 Patients
• Host-microbial interactions in Wegener’s Granulomatosis: The role of ANCA and S. aureus persistence
• The role of shear stress in neutrophil proteinase-3 expression and its importance in vascular injury sites in WG
• Analysis of NKG2D expression on CD28
• Identification of Novel Wegener’s Granulomatosis Susceptibility Genes
• Environmental Factors in the Pathogenesis of Wegener’s Granulomatosis
• Localized Wegener’s Granulomatosis: Epidemiological, clinical and histopathological characteristics
• Wegener’s Granulomatosis and Microscopic Polyarteritis Case Control Study in Western Montana
• Development of a Measure to Assess Patients’ Adherence to Vasculitis Treatment Regimens
• A Pilot Project towards Establishment of a US/Canadian Diagnostic Registry of Children with WG and Related Vasculitides
• Renal transplantation in WG: mortality, allograft outcomes, and incidence of malignancies from the United States
• Identification and characterization of immunodominant, conformational epitopes of anti-neutrophil cytoplasmic antibodies
• Gene Expression Profile of Temporal Arteritis in Giant Cell Arteritis

VF Grant Requirements, Grant Instructions...

Page 4 of 24

Short-term cyclophosphamide therapy...